Modulation of tumor cell gene expression and phenotype by the organspecific metastatic environment (original) (raw)
References
Fidler IJ: Special Lecture: Critical factors in the biology of human cancer metastasis: Twenty-eight G.H.A. Clowes Memorial Award Lecture. Cancer Res 50: 6130–6138, 1990 Google Scholar
Nicolson GL: Cancer progression and growth: Relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis. Expt Cell Res 204: 171–180, 1993 Google Scholar
Fidler IJ, Radinsky R: Editorial: Genetic control of cancer metastasis. J Natl Cancer Inst 82: 166–168, 1990 Google Scholar
Paget S: The distribution of secondary growths in cancer of the breast. Lancet 1: 571–573, 1889 Google Scholar
Hart IR: ‘Seed and soil’ revisited: Mechanisms of site specific metastasis. Cancer Met Rev 1: 5–17, 1982 Google Scholar
Tarin D, Price JE, Kettlewell MGW, Souter RG, Vass ACR, Crossley B: Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Res 44: 3584–3592, 1984 Google Scholar
Radinsky R: Paracrine growth regulation of human colon carcinoma organ-specific metastasis. Cancer Met Rev 12: 345–361, 1993 Google Scholar
Radinsky R, Beltran P, Tsan R, Zhang R, Cone R, Fidler IJ: Transcriptional induction of the melanocyte stimulating hormone receptor in K1735 metastatic murine melanoma cells growing in the brain of nude mice. Cancer Res 55: 141–148, 1995 Google Scholar
Radinsky R, Fidler IJ, Price JE, Esumi N, Tsan R, Petty CM, Bucana CD, Bar-Eli M: Terminal differentiation and apoptosis in experimental lung metastases of human osteogenic sarcoma cells by wild type p53. Oncogene 9: 1877–1883, 1994 Google Scholar
Dong Z, Radinsky R, Fan D, Tsan R, Bucana CD, Wilmanns C, Fidler IJ: Organ-specific modulation of steadystate_mdr_ gene expression and drug resistance in murine colon cancer cells. J Natl Cancer Inst 86: 913–920, 1994 Google Scholar
Radinsky R, Risin S, Fan D, Dong Z, Bielenberg D, Bucana CD, Fidler IJ: Level and function of the epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res 1: 19–31, 1995 Google Scholar
Menter DG, Herrmann JL, Nicolson GL: The role of trophic factors and autocrine/paracrine growth factors in brain metastasis. Clin Exp Metastasis 13: 67–88, 1995 Google Scholar
Schackert G, Fidler IJ: Site-specific metastasis of mouse melanomas and fibrosarcoma in the brain or meninges of syngeneic animals. Cancer Res 48: 3478–3483, 1988 Google Scholar
Fujimaki T, Fan D, Staroselsky AH, Gohji K, Bucana CD, Fidler IJ: Critical factors regulating site-specific brain metastasis of murine melanomas. Int J Oncol 3: 789–799, 1993 Google Scholar
Price JE, Tarin D, Fidler IJ: Influence of the organ environment on pigmentation of a metastatic murine melanoma. Cancer Res 48: 2258–2264, 1988 Google Scholar
Eberle AN: The melanotropins: chemistry, physiology, and mechanism of action. Basel: Karger, 1988 Google Scholar
Clive D, Snell DS: Effect of MSH on mammalian hair color. J Invest Dermatol 49: 314–321, 1972 Google Scholar
Burchill SA, Virden R, Thody AJ: Regulation of tyrosinase and its processing in the hair follicular melanocytes of the mouse during melanogenesis and phaeomelanogenesis. J Invest Dermatol 93: 236–240, 1989 Google Scholar
Pawelek J, Wong G, Sansone M, Morowitz J: Molecular controls in mammalian pigmentation. Yale J Biol Med 46: 430–443, 1973 Google Scholar
Halaban R, Pomerantz SH, Marshall S, Lambert DT, Lerner AB: Regulation of tyrosinase in human melanocytes grown in culture. J Cell Biol 97: 480–488, 1983 Google Scholar
Fuller BB, Meyskins FL: Endocrine responsiveness in human melanocytes and melanoma cells in culture. J Natl Cancer Inst 66: 799–802, 1981 Google Scholar
Friedman PS, Wren F, Buffey J, MacNeil S: α-MSH causes a small rise in cAMP but has no effect on basal or ultraviolet-stimulated melanogenesis in human melanocytes. Br J Dermatol 123: 145–151, 1990 Google Scholar
Seechurn P, Thody AJ: The effect of UV-irradiation and MSH on tyrosinase activity in epidermal melanocytes of the mouse. J Dermatol Sci 1: 283–288, 1990 Google Scholar
Halaban R, Pomerantz SH, Marshall S, Lerner AB: Tyrosinase activity and its abundance in Cloudman melanoma cells. Arch Biochem Biophys 230: 383–387, 1984 Google Scholar
Hill S, Buffey J, Thody AJ, Oliver I, Bleehen SS, MacNeil S: Investigation of the regulation of pigmentation in melanocyte-stimulating hormone responsive and unresponsive cultured B16 murine melanoma cells. Pigment Cell Res 2: 161–166, 1989 Google Scholar
Salomon Y, Zohar M, DeJordy JO, Eshel Y, Shafir I, Lieba H, Garty NB, Schmidt-Sole J, Azrad A, Shai E, Degani H: Signaling mechanisms controlled by melanocortins in melanoma, lacrimal, and brain astroglia cells. Ann NY Acad Sci 680: 364–380, 1993 Google Scholar
Mountjoy KG, Robbins LS, Mortrud MT, Cone RD: The cloning of a family of genes that encode the melanocortin receptors. Science 257: 1248–1251, 1992 Google Scholar
Chhajlani V, Wiberg JES: Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett 3: 417–420, 1992 Google Scholar
Kameyama K, Montague PM, Hearing VJ: Expression of melanocyte stimulating hormone receptors correlates with mammalian pigmentation and can be modulated by interferons. J Cell Physiol 137: 35–44, 1988 Google Scholar
Solca FF, Chluba-de Tapia J, Iwata K, Eberle AN: B16G4F mouse melanoma cells: an MSH receptor-deficient cell clone. FEBS Lett 322: 177–180, 1993 Google Scholar
Kameyama K, Tanaka S, Ishida Y, Hearing VJ: Interferons modulate the expression of hormone receptors on the surface of melanoma cells. J Clin Invest 83: 213–221, 1989 Google Scholar
Sheppard JR, Koestler JP, Corwin SP, Buscarino C, Doll J, Lester B, Greig RG, Poste G: Experimental metastasis correlates with cyclic AMP accumulation in B16 melanoma clones. Nature 308: 544–547, 1984 Google Scholar
Lunec J, Pieron C, Thody AJ: MSH receptor expression and the relationship to melanogenesis and metastatic activity in B16 melanoma. Melanoma Res 2: 5–12, 1992 Google Scholar
Bennett DC, Dexter TJ, Ormerod EJ, Hart IR: Increased experimental metastatic capacity of a murine melanoma following induction of differentiation. Cancer Res 46: 3239–3244, 1986 Google Scholar
Lakshmi MS, Parker C, Sherbet GV: Metastasis associated MTS1 and NM23 genes affect tubulin polymerisation in B16 melanomas: a possible mechanism of their regulation of metastatic behavior of tumours. Anticancer Res 13: 299–304, 1993 Google Scholar
Cannon JG, Tatro JB, Reichlin S, Dinarello CA: Melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1. J Immunol 137: 2232–2236, 1986 Google Scholar
Krasagakis K, Garbe C, Orfanos CE: Cytokines in human melanoma cells: Synthesis, autocrine stimulation and regulatory functions - an overview. Melanoma Res 3: 425–433, 1993 Google Scholar
Singh RK, Gutman G, Radinsky R: Heterogeneity of cytokine and growth factor gene expression in human melanoma cells with different metastatic potentials. J Interferon Cytokine Res 15: 81–87, 1995 Google Scholar
Gutman M, Singh RK, Radinsky R, Bar-Eli M: Intertumoral heterogeneity of receptor-tyrosine kinases expression in human melanoma cell lines with different metastatic capabilities. Anticancer Res 14: 1759–1766, 1994 Google Scholar
Siegrist W, Stutz S, Eberle AN: Homologous and heterologous regulation of α-melanocyte-stimulating hormone receptors in human and mouse melanoma cell lines. Cancer Res 54: 2604–2610, 1994 Google Scholar
Fisher PB, Grant S: Effects of interferon on differentiation of normal and tumor cells. Pharmacol Ther 27: 143–166, 1985 Google Scholar
Giacomini P, Imberti L, Agussi A, Fisher PB, Trinchieri G, Ferrone S: Immunocytochemical analysis of the modulation of human melanoma-associated antigens by DNA recombinant immune interferon. J Immunol 135: 2887–2894, 1985 Google Scholar
Lotan R, Lotan D: Enhancement of melanotic expression in cultured mouse melanoma cell by retinoids. J Cell Physiol 106: 179–189, 1981 Google Scholar
Hosoi J, Abe E, Suda T, Kuroki T: Regulation of melanin synthesis of B16 mouse melanoma cells by 1,25-dihydroxy vitamin D3 and retinoic acid. Cancer Res 45: 1474–1478, 1985 Google Scholar
Friedman PS, Gilchrest BA: Ultraviolet radiation directly induces pigment production by cultured human melanocytes. J Cell Physiol 133: 88–94, 1987 Google Scholar
Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkison BO, Cone RD: Agouti protein is an antagonist of the melanocyte-stimulating hormone receptor. Nature 371: 799–802, 1994 Google Scholar
Varga JM, Asato N, Lande S, Lerner AB: Melanotropin-daunomycin conjugate shows receptor-mediated cytotoxicity in cultured murine melanoma cells. Nature 267: 56–58, 1977 Google Scholar
Liu MA, Nussbaum SR, Eisen HN: Murine, not human, cell line. Science 239: 1227, 1988 Google Scholar
Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B: Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705–708, 1989 Google Scholar
Hollstein M, Sidransky D, Vogelstein B, Harris C: p53 mutations in human cancers. Science 253: 49–53, 1991 Google Scholar
Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B: Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355: 846–847, 1992 Google Scholar
Vogelstein B, Kinzler KW: p53 function and dysfunction. Cell 70: 523–526, 1992 Google Scholar
Gannon JV, Greaves R, Iggo R, Lane DP: Activating mutations in p53 produce a common conformational effect. EMBO J 9: 1595–1602, 1990 Google Scholar
Kern SE, Kinzler KW, Baker SJ, Nigro JM, Rotter V, Levine AJ, Friedman P, Prives C, Vogelstein B: Abnormal DNA-binding and phosphorylation of mutant p53 protein_in vitro_. Oncogene 6: 131–136, 1991 Google Scholar
Diller L, Kassel J, Nelson CE, Gryka MA, Litwak G, Gebhardt M, Bressac B, Oztork M, Baker SJ, Vogelstein B, Friend SH: p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol 10: 5772–5781, 1990 Google Scholar
Motyka B, Reynolds JD: Apoptosisis is associated with the extensive B cell death in the sheep ileal Peyer's patch and the chicken bursa of_Fabricius_: A possible role in B cell selection. Eur J Immunol 21: 1951–1958, 1991 Google Scholar
Lin D, Shields MT, Ullrich SJ, Appella E, Mercer WE: Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. Proc Natl Acad Sci USA 89: 9210–9214, 1992 Google Scholar
Foti A, Ahuja HG, Allen SL, Koduru P, Schuster MW, Schulman P, Bar-Eli M, Cline MJ: Correlation between molecular and clinical events in the evolution of CML to blast crisis. Blood 77: 2441–2444, 1991 Google Scholar
Ahuja HG, Bar-Eli M, Arlin Z, Advani S, Allen S, Goldman J, Snyder D, Foti A, Cline MJ: The spectrum of molecular alterations in the evolution of chronic myelogenous leukemia. J Clin Invest 87: 2042–2047, 1991 Google Scholar
Masuda H, Miller C, Koeffler HP, Battifora H, Cline MJ: Rearrangement of the p53 gene in human osteosarcomas. Proc Natl Acad Sci USA 84: 7716–7719, 1987 Google Scholar
Oren M: The involvement of oncogenes and tumor suppressor genes in the control of apoptosis. Cancer Metastasis Rev 11: 141–148, 1992 Google Scholar
Lane DP: A death in the life of p53. Nature 362: 786–787, 1993 Google Scholar
Owen-Schaub LB, Zhang W, Cusack JC, Angelo LS, Santee SM, Fujiwara T, Roth JA, Deisseroth AB, Zhang W-W, Kruzel E, Radinsky R: Wild-type human p53 and a temperature-sensative mutant induce Fas/APO-1 expression. Mol Cell Biol 15: 3032–3040, 1995 Google Scholar
Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M: Wild-type p53 induces apoptosis of myeloid leukemia cells that is inhibited by interleukin-6. Nature 352: 345–347, 1991 Google Scholar
Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J: Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 89: 4495–4499, 1992 Google Scholar
Shaulsky G, Goldfinger N, Rotter V: Alterations in tumor development_in vivo_ mediated by expression of wild type or mutant p53 proteins. Cancer Res 51: 5232–5327, 1991 Google Scholar
Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849–852, 1993 Google Scholar
Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847–884, 1993 Google Scholar
Bar-Shavit Z, Teitelbaum SL, Reitsma P, Hall A, Pegg LE, Trial J, Kahn AJ: Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 80: 5907–5911, 1983 Google Scholar
Key L, Carnes D, Cole S, Holtrop M, Bar-Shavit Z, Shapiro F, Arceci R, Steinberg J, Gundberg C, Kahn A, Teitelbaum S, Anast C: Treatment of congenital osteoperosis with high-dose calcitriol. N Engl J Med 310: 409–415, 1984 Google Scholar
Rodan GA, Rodan SB: Expression of the osteoblastic phenotype. In: Peck WA (ed) Advances in Bone and Mineral Research, Annual II pp 244–285 Amsterdam: Excerpta Medica, 1984 Google Scholar
Rodan SB, Imai Y, Thiede MA, Wesolowski G, Thompson D, Bar-Shavit Z, Shull S, Mann K, Rodan GA: Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. Cancer Res 47: 4961–4966, 1987 Google Scholar
Spiess YR, Price PA, Deftos JL, Manolagas SC: Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells. Endocrinology 118: 1340–1346, 1986 Google Scholar
Elias L, Berry CO: Induction of differentiation by tumour necrosis factor in HL-60 cells is associated with the formation of large DNA fragments. Leukemia 5: 879–885, 1991 Google Scholar
Deisseroth AB, Roth JA: Editorial: Applications and advances in gene therapy. Ca Bulletin 45: 107–108, 1993 Google Scholar
Chin K-V, Pastan I, Gottesman MM: Function and regulation of the human multidrug resistance gene. Adv Ca Res 60: 157–180, 1993 Google Scholar
Germann UA, Pastan I, Gottesman MM: P-glycoproteins: Mediators of multidrug resistance. Semin Cell Biol 4: 63–76, 1993 Google Scholar
Rothenberg M, Ling V: Multidrug resistance: Molecular biology and clinical relevance. J Natl Cancer Inst 81: 907–910, 1989 Google Scholar
Croop JM, Gros P, Housman DE: Genetics of multidrug resistance. J Clin Invest 81: 1303–1309, 1988 Google Scholar
Kanamaru H, Kakehi Y, Yoshida O, Nakanishi S, Pastan I, Gottesman MM: MDR1 RNA levels in human renal cell carcinomas: Correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants. J Natl Cancer Inst 81: 844–849, 1989 Google Scholar
Chabner BA, Foji A: Multidrug resistance: P-glycoprotein and its allies - the elusive foes. J Natl Cancer Inst 81: 910–913, 1989 Google Scholar
Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pinker R, Green A, Grist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM, Pastan I: Expression of a multidrug resistance gene in human tumors. J Natl Cancer Inst 81: 116–124, 1989 Google Scholar
Weinstein RS, Shriram JM, Dominguez JM, Lebovitz MD, Koukoulis GK, Kuszak JR, Klusens LF, Grogen TM, Saclarides TJ, Ronnison IB, Coon JS: Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res 51: 2720–2726, 1991 Google Scholar
Park J, Kramer BS, Lai S, Goldstein LJ, Gazdar AF: Chemosensitivity patterns and expression of human multidrug resistance-associated MDR1 gene by human gastric and colorectal carcinoma cell lines. J Natl Cancer Inst 82: 193–198, 1990 Google Scholar
Morrow CS, Cowan KH: Mechanisms and clinical significance of multidrug resistance. Oncology 2: 55–63, 1988 Google Scholar
Dalton WS, Grogan TM: Does P-glycoprotein predict response to chemotherapy, and if so, is there a reliable way to detect it? J Natl Cancer Inst 83: 80–81, 1991 Google Scholar
Raymond M, Rose E, Housman DE, Gros P: Physical mapping, amplification, and overexpression of the mouse_mdr_ gene family in multidrug-resistant cells. Molec Cell Biol 10: 1642–1651, 1990 Google Scholar
Croop JM, Raymond M, Haber D, Devault A, Arceci RJ, Gros P, Housman DE: The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Molec Cell Biol 9: 1346–1350, 1989 Google Scholar
Devault A, Gros P: Two members of the mouse_mdr_ gene family confer multidrug resistance with overlapping but distinct drug specificities. Molec Cell Biol 10: 1652–1663, 1990 Google Scholar
Hsu SIH, Lothstein L, Horwitz SB: Differential overexpression of three_mdr_ gene family members in multidrug resistant J774.2 cells. Evidence that distinct P-glycoprotein precursors are encoded by unique_mdr_ genes. J Biol Chem 246: 12053–12062, 1989 Google Scholar
Ruetz S, Gros P: Phosphatidylcholine translocase: A physiological role for the_mdr_ 2 gene. Cell 77: 1071–1081, 1994 Google Scholar
Arceci RJ, Croop JM, Horwitz SB, Housman DE: The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc Natl Acad Sci USA 85: 4350–4354, 1988 Google Scholar
Slack NH, Bross JDJ: The influence of site of metastasis on tumor growth and response to chemotherapy. Br J Cancer 32: 78–86, 1975 Google Scholar
Donelli MG, Russo R, Garattini S: Selective chemotherapy in relation to the site of tumor transplantation. Int J Cancer 32: 78–86, 1975 Google Scholar
Teicher BA, Herman TS, Holden SA, Wang Y, Pfeffer MR, Crawford JW, Frei E: Tumor resistance to alkylating agents conferred by mechanisms operative only_in vivo_. Science 247: 1457–1461, 1990 Google Scholar
Wilmanns C, Fan D, O'Brian CA, Bucana CD, Fidler IJ: Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5-fluorouracil. Int J Cancer 52: 98–104, 1992 Google Scholar
Staroselsky A, Fan D, O'Brian CA, Gupta KP, Fidler IJ: Site-dependent differences in response of the UV-2237 murine fibrosarcoma to systemic therapy with Adriamycin. Cancer Res 50: 7775–7780, 1990 Google Scholar
Wilmanns C, Fan D, O'Brian CA, Radinsky R, Bucana CD, Tsan R, Fidler IJ: Modulation of doxorubicin sensitivity and level of P-glycoprotein expression in human colon carcinoma cells by ectopic and orthotopic environments in nude mice. Int J Oncol 3: 412–422, 1993 Google Scholar
Bradley G, Sharma R, Rajalakshmi S, Ling V: P-glycoprotein expression during tumor progression in the rat liver. Cancer Res 52: 5154–5161, 1992 Google Scholar
Herzog CE, Tsokos M, Bates SE, Fojo AT: Increased mdr-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists. J Biol Chem 268: 2946–2952, 1993 Google Scholar
Schuurhuis GJ, Broxterman HJ, de Lange JH, Pinedo HM, van Heijningen TH, Kuiper CM, Scheffer GL, Scheper RJ, van Kalken CK, Baak JP: Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein. Br J Cancer 64: 857–861, 1991 Google Scholar
Fidler IJ, Wilmanns C, Staroselsky A, Radinsky R, Dong Z, Fan D: Modulation of tumor cell response to chemotherapy by the organ environment. Cancer Met Rev 13: 209–222, 1994 Google Scholar
Kerbel RS, Kobayashi H, Graham CH: Intrinsic or acquired drug resistance and metastasis: Are they linked phenotypes? J Cell Biochem 56: 37–47, 1994 Google Scholar
Russell AH, Tong D, Dawson LE, Wisbeck W: Adenocarcinoma of the proximal colon: Sites of initial dissemination and patterns of recurrence following surgery alone. Cancer 53: 360–367, 1984 Google Scholar
Giavazzi R, Campbell DE, Jessup JM, Cleary KR, Fidler IJ: Metastatic behavior of tumor cells from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice. Cancer Res 46: 1928–1933, 1986 Google Scholar
Giavazzi R, Jessup JM, Campbell DE, Walker SM, Fidler IJ: Experimental nude mouse model of human colorectal cancer liver metastases. J Natl Cancer Inst 77: 1303–1308, 1986 Google Scholar
Morikawa K, Walker SM, Jessup JM, Fidler IJ:In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res 48: 1943–1948, 1988 Google Scholar
Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM, Fidler IJ: Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res 48: 6863–6871, 1988 Google Scholar
Gutman M, Singh RK, Price JE, Fan D, Fidler IJ: Accelerated growth of human colon cancer cells in nude mice undergoing liver regeneration. Invasion Metastasis 95: 362–371, 1994 Google Scholar
Grupposo PA, Mead JE, Fausto N: Transforming growth factor receptors in liver regeneration following partial hepatectomy in the rat. Cancer Res 50: 1464–1469, 1990 Google Scholar
Mead JE, Fausto N: Transforming growth factor α may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci USA 86: 1558–1562, 1989 Google Scholar
Noji S, Tashiro K, Koyama E, Nohno T, Ohyama K, Taniguchi S, Nakamura T: Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by_in situ_ hybridization. Biochem Biophys Res Common 173: 42–47, 1990 Google Scholar
Markowitz SD, Molkentin K, Gerbic C, Jackson J, Stellato T, Willson JKV: Growth stimulation by coexpression of transforming growth factor - and epidermal growth factor receptor in normal and adenomatous human colon epithelium. J Clin Invest 86: 356–362, 1990 Google Scholar
Van der Geer P, Hunter T, Lindberg RA: Receptor proteintyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol 10: 251–337, 1994 Google Scholar
Sainsbury JRC, Sherbert GV, Farndon JR, Harris AL: Epidermal growth factor receptors and oestrogen receptors in human breast cancer. Lancet i: 364–366, 1986 Google Scholar
Bigner SH, Humphrey PA, Wong AJ, Vogelstein B, Mark J, Friedman HS, Bigner DD: Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Res 50: 8017–8022, 1990 Google Scholar
Harris AL, Neal DE: Epidermal growth factor and its receptor in human cancer. In: Sluyser M (ed) Growth Factors and Oncogenes in Breast Cancer, pp 60–90, 1987
Neal DE, Marsh C, Bennet MK, Abel PD, Hall RR, Sainsbury JRC, Harris AL: Epidermal growth factor receptor in human bladder cancer: Comparison of invasive and superficial tumours. Lancet i: 366–368, 1985 Google Scholar
Gullick WJ, Marsden JJ, Whittle N, Ward B, Bobrow L, Waterfield MD: Expression of epidermal growth factor receptors on human cervical, ovarian, and vulvar carcinomas. Cancer Res 46: 285–292, 1986 Google Scholar
Ullrich AL, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Whittle ELV, Waterfield MD, Seeburg PH: Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (London) 309: 418–425, 1984 Google Scholar
Scher HI, Sarkis A, Reuter V, Cohen D, Netto G, Petrylak D, Lianes P, Fuks Z, Mendelsohn J, Cordon-Cardo C: Changing patterns of expression of the epidermal growth factor receptor and transforming growth factor a in the progression of prostatic neoplasms. Clin Ca Res 1: 545–550, 1995 Google Scholar
Gross ME, Zorbas MA, Daniels YJ, Garcia R, Gallick GE, Olive M, Brattain MG, Boman BM, Yeoman LC: Cellular growth response to epidermal growth factor in colon carcinoma cells with an amplified epidermal growth factor receptor derived from a familial adenomatous polyposis patient. Cancer Res 51: 1452–1459, 1991 Google Scholar
Steiner MG, Harlow SP, Colombo E, Bauer KD: Chromosomes 8, 12, and 17 copy number in Astler-Coller stage C colon cancer in relation to proliferative activity and DNA ploidy. Cancer Res 53: 681–686, 1993 Google Scholar
Waldman FM, Carroll PR, Kerschmann R, Cohen MB, Field FG, Mayall BH: Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res 51: 3807–3813, 1991 Google Scholar
Kern SE, Fearon ER, Tersmette KWF, Enterline JP, Leppert M, Nakamura Y, White R, Vogelstein B, Hamilton SR: Allelic loss in colorectal carcinoma. JAMA 261: 3099–3103, 1989 Google Scholar
Collard JG, Roos E, La Riviere G, Habets GGM: Genetic analysis of invasion and metastasis. Cancer Surveys 7: 691–710, 1988 Google Scholar
Koprowski H, Herlyn M, Balaban G, Parmiter A, Ross A, Nowell P: Expression of the receptor for epidermal growth factor correlates with increased dosage of chromosome 7 in malignant melanoma. Somatic Cell Molec Genet 11: 297–302, 1985 Google Scholar
Korc M, Meltzer P, Trent J: Enhanced expression of epidermal growth factor receptor correlates with alterations of chromosome 7 in human pancreatic cancer. Proc Natl Acad Sci USA 83: 5141–5144, 1986 Google Scholar
Henn W, Blin N, Zang K: Polysomy of chromosome 7 is correlated with overexpression of the_erb_B oncogene in human glioblastoma cell lines. Hum Genet 74: 104–106, 1986 Google Scholar
Radinsky R, Bucana CD, Ellis LE, Sanchez R, Cleary KR, Brigati DJ, Fidler IJ: A rapid colorimetric_in situ_ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas. Cancer Res 53: 937–943, 1993 Google Scholar
Khazaie K, Schirrmacher V, Lichtner RB: EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev 12: 255–274, 1993 Google Scholar
Modjtahedi H, Dean C: The receptor for EGF and its ligands: Expression, prognostic value and target for therapy in cancer (Review). Int J Oncol 4: 277–296, 1994 Google Scholar
Mendelsohn J: The epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies. Semin Cancer Biol 1: 339–344, 1990 Google Scholar
Baselga J, Norton L, Masui H, Pandiella A, Coplan K, Miller Jr WH, Mendelsohn J: Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J Natl Cancer Inst 85: 1327–1333, 1993 Google Scholar
Fan Z, Masui H, Altaws I, Mendelsohn J: Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res 53: 4322–4328, 1993 Google Scholar
Phillips PC, Levow C, Catterall M, Colvin OM, Pastan, Brem H: Transforming growth factor-α-Pseudomonas exotoxin fusion protein (TGF-α-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice. Cancer Res 54: 1008–1015, 1994 Google Scholar
Siegall CB, FitzGerald DJ, Pastan I: Selective killing of tumor cells using EGF or TGFα-Pseudomonas exotoxin chimeric molecules. Semin Cancer Biol 1: 345–350, 1990 Google Scholar
Lofts FJ, Hurst HC, Sterberg MJE, Gullick WJ: Specific short transmembrane sequences can inhibit transformation by the mutant_neu_ growth factor receptor_in vitro_ and_in vivo_. Oncogene 8: 2813–2820, 1993 Google Scholar
Fry DW, Kraker AJ, McMichael A, Ambroso LA, Nelson JM, Leopoid WR, Connors RW, Bridges AJ: A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science 265: 1093–1095, 1994 Google Scholar
Kashles O, Yarden Y, Fischer R, Ullrich A, Schlessinger J: A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization. Mol Cell Biol 11: 1454–1463, 1991 Google Scholar
Selva E, Raden DL, Davis RJ: Mitogen-activated protein kinase stimulation by a tyrosine kinase-negative epidermal growth factor receptor. J Biol Chem 268: 2250–2254, 1993 Google Scholar